Aadi Biosciences
AADI2.0500.00% ( 0.000 )
Aadi Biosciences (AADI)
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alteratio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 2.050
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- prnewswire · May 7 at 06:45 AM
07:45 ETAdvaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
- StockTitan · Apr 21 at 11:00 PM
Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year | ADIA Stock News
- Market Beat · Apr 16 at 11:53 PM
Aadi Bioscience (NASDAQ:AADI) Stock Price Down 2.5% - Here's What Happened
- TradingView · Apr 14 at 03:15 PM
BIOADAPTIVES 2025 10-K: Revenue $18,278, EPS $(0.15)
- StockTitan · Apr 7 at 11:35 PM
Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study | ADIA Stock News
- StockTitan · Apr 1 at 01:07 AM
Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status | ADIA Stock News
